PTPI

Petros Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$68.59 sample

+0.34 (+0.50%) 1D

Market cap

$137.8B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-16

Alerts

8

Price$68.59 +16.63% 3M daily closessample

69.3258.81

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider sell: Director
Sep 16SEC8-K filed: material event
Sep 07SEC10-Q filed
Aug 27INSInsider buy: General Counsel
Aug 20INSInsider buy: Chief Executive Officer
Aug 17INSInsider buy: General Counsel
Aug 10INSInsider sell: General Counsel
Jul 31INSInsider sell: 10% owner

Sign up to see the real PTPI record →

Company facts

SEC EDGAR registration

Name: Petros Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +7sample, -100 to +100
Reporting currency: USD

Who is positioning in PTPI

sample

Insiders: 7 insider transactions over 90 days, net selling, $583.2M
Congress: 1 members traded over 90 days
Institutions · 13F: 34 funds hold $1.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.9B +15.1% y/y

Q4 2024Q3 2026

Inventory$4.5B +4.3% y/y

Q4 2024Q3 2026

Accounts receivable$3.4B +5.3% y/y

Q4 2024Q3 2026

Total debt$8.9B +5.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $86.4B +15.3% 3M
Sample peer B: $25.6B +12.8% 3M
Sample peer C: $15.1B +9.1% 3M
Sample peer D: $110.5B -3.1% 3M
Sample peer E: $122.8B -7.5% 3M